To test this phenotype as AD pathology progresses with aging, we repeated this experiment using 13 mo female 3xTg and WT mice, which have more advanced amyloid and tau pathology (Figures 1H, I), though they still lack plaques and phosphorylated tau in the SCN (Supplementary Figure 1B). The gene discussed is MAPT; the disease is Alzheimer disease.